Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Maryland, College Park $107,090 under the Drug Use and Addiction Research Programs (CFDA 93.279) on February 15, 2026, with a completion date of February 14, 2028. This project grant funds longitudinal research investigating how trajectories of perinatal substance use (PSU) and perinatal depression (PD) jointly impact neonatal brain development, specifically infant hippocampal volume and...
Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Maryland, College Park $248,717 under the Drug Use and Addiction Research Programs (CFDA 93.279) to support fundamental neuroscience research investigating the neural mechanisms underlying cognitive learning and decision-making. The project, titled "Probing the Mechanisms and Circuits Underlying Orbitofrontal Signaling," operates from August 1, 2025, through July 31, 2028, and...
Federal Project Grant Summary Northwestern University's Sponsored Research Division received a $722,218 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective March 1, 2026, through December 31, 2030. The project, "Effects of Developmental Environment on Dopamine Circuit Structure and Function," delivers fundamental neuroscience research addressing how early life stress produces long-lasting impacts...
Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded University of California, Berkeley a $707,108 Project Grant effective September 1, 2025, through August 31, 2027, under the Drug Use and Addiction Research Programs (CFDA 93.279). The project, titled "The International Development Project (IDP): An International Collaboration for the Standardized Study of Experience-Dependent Brain and Behavioral Development," establishes the Adversity and...
Federal Grant Award Summary The University of Maryland, College Park received a $183,873 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded May 15, 2026, with completion targeted for April 30, 2031. This K23 career development award funds the ROOTS (Recovery Opportunities Through Ongoing Treatment Sustainment) initiative, which examines implementation strategies for integrating substance use disorder services...
Federal Grant Award Summary American University received a $476,496 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 15, 2025, and concluding July 31, 2028. The grant funds fundamental neuroscience research investigating opioid signaling mechanisms in reward-guided decision-making within the rat prefrontal cortex, specifically the prelimbic area. The research employs a two-alternative forced choice...
Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Maryland, Baltimore a $2.21 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct joint decomposition analysis of multi-omic datasets exploring the impact of substance use disorders (SUD) and human immunodeficiency virus (HIV) on reward circuitry and neuroinflammation. The award, effective September 1, 2025, through May 31, 2030, addresses critical...
Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $423,500 to the Regents of the University of Minnesota under the Drug Use and Addiction Research Programs (CFDA 93.279) on April 1, 2026, for a two-year project period concluding March 31, 2028. This project grant supports research investigating the therapeutic potential of muscarinic M5 receptor targeting in stress-induced potentiation of drug reward. The research will examine how stress-induced disruption...
Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $107,386 to the University of Maryland, College Park under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a single-session, peer-delivered intervention targeting internalized stigma reduction for individuals with polysubstance use disorder in rural Maryland. The project, which commenced on May 15, 2026 and concludes April 30, 2028, addresses a critical gap in substance use disorder...
Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded UC San Diego a $197,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2027. The award supports development and validation of an in vivo Massively Parallel Reporter Assay (MPRA) methodology to characterize the functional role of cis-regulatory elements and genetic variants associated with substance use disorders. Specifically, the...
Federal Project Grant Award Summary
The University of Maryland, College Park received a $152,300 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded August 20, 2026, with a completion date of April 18, 2029. The award funds research investigating the neural and cognitive mechanisms underlying perseverance and resilience, with specific focus on how social play deprivation during critical developmental periods disrupts executive functioning and increases addiction risk. The research employs a rodent model to examine relationships between early-life social experiences and adult decision-making, directly addressing gaps in understanding whether juvenile social play actively shapes neurocognitive development or merely correlates with adult cognitive outcomes.
The research deliverables include development and characterization of a novel Multi-Step Perseverance Task (MSPT) that assesses the balance between motivational drive and behavioral inhibition in response to setbacks. The project will involve single-neuron recording from the anterior cingulate cortex (ACC)—a brain region critical for adaptive behavior—as rats perform the MSPT, with the goal of identifying how neural ensemble firing patterns contribute to psychological constructs mediating effort, perseverance, and resilience. This work addresses the National Institute on Drug Abuse's priority to develop new knowledge on prevention and treatment approaches related to substance use disorder, particularly by elucidating how early adversity and social deprivation influence neurodevelopmental pathways to addiction vulnerability.